Upgrade to SI Premium - Free Trial

Guardant Health (GH) PT Lowered to $90 at Evercore ISI

April 6, 2026 8:28 AM
Evercore ISI analyst Vijay Kumar lowered the price target on Guardant Health (NASDAQ: GH) to $90.00 (from $110.00) while maintaining a In Line rating.

Categories

Analyst PT Change